SII vs. RIGL
SII (Sprott Inc) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. SII operates in Asset Management (Financial Services), while RIGL operates in Biotechnology (Healthcare). Over the past 5 years, SII returned 25.88%/yr vs -1.65%/yr for RIGL. Their 0.15 correlation means their historical movements had little consistent relationship.
Performance
SII vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SII achieves a 5.79% return, which is significantly higher than RIGL's -14.06% return.
SII
- 1D
- -3.43%
- 1M
- -8.62%
- 6M
- -15.56%
- YTD
- 5.79%
- 1Y
- 55.19%
- 3Y*
- 50.62%
- 5Y*
- 25.88%
- 10Y*
- —
- ALL TIME*
- 21.50%
RIGL
- 1D
- -3.28%
- 1M
- -3.87%
- 6M
- 5.59%
- YTD
- -14.06%
- 1Y
- 74.79%
- 3Y*
- 40.40%
- 5Y*
- -1.65%
- 10Y*
- 3.86%
- ALL TIME*
- -10.60%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $11.43M | $14.01M | $13.32M | |
SII Sprott Inc | $12.82M | $17.25M | $21.64M |
SII vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SII Sprott Inc | 5.79% | 137.17% | 27.39% | 5.00% | -24.09% | 59.43% | -19.45% |
RIGL Rigel Pharmaceuticals, Inc. | -14.06% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 90.22% |
Correlation
The correlation between SII and RIGL is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.06 |
Correlation (3Y) Balances recent behavior with more history. | 0.16 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jun 29, 2020 | 0.15 |
Fundamentals
SII:
$2.66B
RIGL:
$681.06M
SII:
$3.62
RIGL:
$18.94
SII:
28.47
RIGL:
1.94
SII:
0.76
RIGL:
0.00
SII:
6.38
RIGL:
2.36
SII:
5.01
RIGL:
1.81
SII:
$377.77M
RIGL:
$299.77M
SII:
$278.09M
RIGL:
$279.95M
SII:
$120.39M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SII vs. RIGL — Risk / Return Rank
SII
RIGL
SII vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sprott Inc (SII) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SII | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.05 | ||
| Sortino ratioReturn per unit of downside risk | -0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.25 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.46 | 1.50 | -0.04 |
| Martin ratioReturn relative to average drawdown | 3.42 | 2.51 | +0.90 |
Loading charts...
Drawdowns
SII vs. RIGL - Drawdown Comparison
The maximum SII drawdown since its inception was -47.81%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for SII and RIGL.
Loading charts...
Drawdown Indicators
| SII | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.81% | -99.37% | +51.56% |
Max Drawdown (1Y)Largest decline over 1 year | -38.01% | -50.08% | +12.07% |
Max Drawdown (3Y)Largest decline over 3 years | -38.01% | -50.76% | +12.75% |
Max Drawdown (5Y)Largest decline over 5 years | -47.81% | -83.85% | +36.04% |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.40% | — |
Current DrawdownCurrent decline from peak | -37.90% | -96.55% | +58.65% |
Average DrawdownAverage peak-to-trough decline | -21.34% | -90.93% | +69.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.20% | 29.86% | -13.66% |
Volatility
SII vs. RIGL - Volatility Comparison
Sprott Inc (SII) and Rigel Pharmaceuticals, Inc. (RIGL) have volatilities of 11.55% and 11.97%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SII | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.55% | 11.97% | -0.42% |
Volatility (6M)Calculated over the trailing 6-month period | 41.12% | 34.77% | +6.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.36% | 70.02% | -20.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.20% | 85.52% | -47.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.00% | 82.76% | -44.76% |
Dividends
SII vs. RIGL - Dividend Comparison
SII's dividend yield for the trailing twelve months is around 1.46%, while RIGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SII Sprott Inc | 1.46% | 1.33% | 2.49% | 2.95% | 3.00% | 2.22% | 1.66% |
Financials
SII vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Sprott Inc and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SII vs. RIGL - Profitability Comparison
SII - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Sprott Inc reported a gross profit of 131.24M and revenue of 143.35M. Therefore, the gross margin over that period was 91.6%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
SII - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Sprott Inc reported an operating income of 41.26M and revenue of 143.35M, resulting in an operating margin of 28.8%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
SII - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Sprott Inc reported a net income of 28.81M and revenue of 143.35M, resulting in a net margin of 20.1%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
SII and RIGL have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (11.97%) compared to SII (11.55%). In terms of maximum drawdown, SII dropped -47.81% vs RIGL's -99.37%.
SII currently has the higher Sharpe Ratio (1.12 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SII and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer